But regardless of the mechanism, the activation of AhR induces CD39 expression in tumor-associated cells, promotes CD8+ T-cell dysfunction (Takenaka et al., 2019), and promotes Treg cell proliferation to induce immunosuppression (Mezrich et al., 2010), thereby enabling the tumor microenvironment. The gene discussed is AHR; the disease is neoplasm.